The costs of publication of this article were defrayed, in part, by the payment of page charges. This article must, therefore, be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Interaction of DIO2 T92A and PPARγ2 P12A Polymorphisms in the Modulation of Metabolic Syndrome
Version of Record online: 6 SEP 2012
2007 North American Association for the Study of Obesity (NAASO)
Volume 15, Issue 12, pages 2889–2895, December 2007
How to Cite
Fiorito, M., Torrente, I., De Cosmo, S., Guida, V., Colosimo, A., Prudente, S., Flex, E., Menghini, R., Miccoli, R., Penno, G., Pellegrini, F., Tassi, V., Federici, M., Trischitta, V. and Dallapiccola, B. (2007), Interaction of DIO2 T92A and PPARγ2 P12A Polymorphisms in the Modulation of Metabolic Syndrome. Obesity, 15: 2889–2895. doi: 10.1038/oby.2007.343
- Issue online: 6 SEP 2012
- Version of Record online: 6 SEP 2012
- Received for review February 20, 2007, Accepted in final from April 25, 2007
- 13Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285: 2486–2497.